Pfizer Inc. is a leading pharmaceutical company that manufactures and markets products to treat various conditions ranging from cardiovascular, cancer, immune disorders, and even rare disorders.
The company is also actively involved in manufacturing sterile injectable pharmaceuticals, active pharmaceutical ingredients (APIs), and biosimilars. This famous pharmaceutical company's product portfolio includes many generic and patented drugs and APIs.
The company recently bolstered its efforts to fight against the COVID-19 pandemic and launched the Pfizer-BioNTech COVID-19 vaccine. The US FDA granted Pfizer approval for emergency use of the vaccine to prevent the spread of the novel coronavirus infection in individuals 12 years and older.
Apart from making waves with the COVID-19 vaccine, Pfizer also has many innovative vaccines in its portfolio, including for the prevention of pneumococcal disease, meningococcal disease, and many others. The company also has an advanced pipeline of vaccines focused on infectious diseases.
This complete and comprehensive analysis of Pfizer includes an overview of the industry the company operates in and the impact of the COVID-19 pandemic on the pharmaceutical industry.
Company analysis includes a history of Pfizer, a business segment analysis of the segments Pfizer operates through, a look at the organization structure of the company, its product pipeline, investment analysis, a geographical operating segments analysis, and how Pfizer has been working at the forefront during the COVID-19 pandemic are all analyzed comprehensively in this report.
The major competitors of Pfizer, namely AstraZeneca, Eli Lilly and Co., and Abbott Laboratories, are analyzed through a company profile, in-depth business segment analysis, a financial analysis, and SWOT analysis.
An economic analysis of Pfizer is also presented through ratio analysis, profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Pfizer completes this in-depth company analysis.
The company is also actively involved in manufacturing sterile injectable pharmaceuticals, active pharmaceutical ingredients (APIs), and biosimilars. This famous pharmaceutical company's product portfolio includes many generic and patented drugs and APIs.
The company recently bolstered its efforts to fight against the COVID-19 pandemic and launched the Pfizer-BioNTech COVID-19 vaccine. The US FDA granted Pfizer approval for emergency use of the vaccine to prevent the spread of the novel coronavirus infection in individuals 12 years and older.
Apart from making waves with the COVID-19 vaccine, Pfizer also has many innovative vaccines in its portfolio, including for the prevention of pneumococcal disease, meningococcal disease, and many others. The company also has an advanced pipeline of vaccines focused on infectious diseases.
This complete and comprehensive analysis of Pfizer includes an overview of the industry the company operates in and the impact of the COVID-19 pandemic on the pharmaceutical industry.
Company analysis includes a history of Pfizer, a business segment analysis of the segments Pfizer operates through, a look at the organization structure of the company, its product pipeline, investment analysis, a geographical operating segments analysis, and how Pfizer has been working at the forefront during the COVID-19 pandemic are all analyzed comprehensively in this report.
The major competitors of Pfizer, namely AstraZeneca, Eli Lilly and Co., and Abbott Laboratories, are analyzed through a company profile, in-depth business segment analysis, a financial analysis, and SWOT analysis.
An economic analysis of Pfizer is also presented through ratio analysis, profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Pfizer completes this in-depth company analysis.
Table of Contents
A. Executive Summary
B. Looking at the Industry
C. Looking at Pfizer, Inc.
D. Looking at Business
E. Pfizer: SWOT Framework Analysis
F. Profiling the Competition
G. Pfizer: Financial Analysis of the Company
Companies Mentioned
- Abbott Laboratories
- AstraZeneca
- Eli Lilly and Co.
- Pfizer
